Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

CWZ, Nijmegen

Mount Sinai Faculty Practice Associates, New York

Montefiore Hospital, The Bronx

Queens Hospital Center (QHC) - Queens Cancer Center, Jamaica

Stony Brook University, Stony Brook

The Urologic Institute of Northeastern New York - Community, Albany

MidLantic Urology, Philadelphia

Thomas Jefferson University, Philadelphia

Klinik und Poliklinik fur Urologie, Hamburg

Chesapeake Urology Research Associates, Towson

Johns Hopkins University, Baltimore

University of Virginia - Health Science Center, Charlottesville

Virginia Oncology Associates PC, Norfolk

Duke University Medical Center, Durham

Emory University Hospital, Atlanta

Northside Hospital, Austell

University of Alabama at Birmingham, Birmingham

University Hospitals Cleveland Medical Center, Cleveland

Cleveland Clinic, Cleveland

Richard L Roudebush VA Medical Center, Indianapolis

University of Michigan, Ann Arbor, Ann Arbor

Karmanos Cancer Institute, Detroit

Loyola University Medical Center, Maywood

NorthShore University HealthSystem, Evanston

Washington University School of Medicine, St Louis

MD Anderson Hospital, Houston

Urology San Antonio, San Antonio

TU München, Munich

Tower Urology, Los Angeles

John Wayne Cancer Institute, Santa Monica

University of California Irvine Medical Center (UCIMC), Orange

Brigham and Women's Hospital, Boston

Turku University Hospital, Turku

Maxima MC, Veldhoven